Received Mar 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
received a dose of Twinrix on September 2024; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a adult patient who received HAB (Twinrix) for prophylaxis. Previously administered products included Twinrix (received a dose in September 2024). On an unknown date, the patient did not receive the 2nd dose of Twinrix. On an unknown date, an unknown time after receiving Twinrix, the patient experienced incomplete course of vaccination (Verbatim: received a dose of Twinrix on September 2024). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 13-MAR-2025 The pharmacist reported that a patient received a dose of Twinrix on September 2024 and in October a dose of Havrix Hepatitis A was administered in unknown location. The reporter asked how to continue with the schedule. Till the time of reporting, the patient did not receive 2nd dose of Twinrix, which led to incomplete course of vaccination.